Stereotactic Breast Biopsy Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET INTRODUCTION
A stereotactic breast biopsy is a procedure that uses mammography to identify and biopsy an abnormality within the breast precisely. It's typically done when the radiologist sees a suspicious abnormality on mammogram that can't be felt in a physical exam.
MARKET DYNAMICS
The stereotactic breast biopsy market is driven by increasing demand for novel drug delivery systems, rising prevalence of chronic diseases. However, high operational costs, discontinuation of products, monopoly in manufacturing & sourcing, lack of standard usage guidelines & trained manpower and lack of proper treatment/diagnosis options for diseases are some of the factors expected to hamper the growth of the global sterile injectable drugs market over the forecast period. Moreover, the rising demand for injectable drug delivery is driving injectable drugs development and growth of sterile injectable drugs in health management associations.
MARKET SCOPE
The "Stereotactic Breast Biopsy Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of stereotactic breast biopsy market with detailed market segmentation by test, test type and end user. The stereotactic breast biopsy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in stereotactic breast biopsy market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The stereotactic breast biopsy market is segmented on the basis of test, test type and end user. Based on test, the market is segmented . On the basis of test type, the market is categorized as core-needle aspiration and vacuum-assisted core biopsy. On the basis of end user, the market is categorized as hospitals, ambulatory surgical centers and specialty clinics.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the stereotactic breast biopsy market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The stereotactic breast biopsy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting stereotactic breast biopsy market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the stereotactic breast biopsy market in these regions.
By Type
By Test Type
By End User
MARKET PLAYERS
The report covers key developments in the stereotactic breast biopsy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from stereotactic breast biopsy market are anticipated to have lucrative growth opportunities in the future with the rising demand for stereotactic breast biopsy in the global market. Below mentioned is the list of few companies engaged in the stereotactic breast biopsy market.
The report also includes the profiles of key players in stereotactic breast biopsy market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
A stereotactic breast biopsy is a procedure that uses mammography to identify and biopsy an abnormality within the breast precisely. It's typically done when the radiologist sees a suspicious abnormality on mammogram that can't be felt in a physical exam.
MARKET DYNAMICS
The stereotactic breast biopsy market is driven by increasing demand for novel drug delivery systems, rising prevalence of chronic diseases. However, high operational costs, discontinuation of products, monopoly in manufacturing & sourcing, lack of standard usage guidelines & trained manpower and lack of proper treatment/diagnosis options for diseases are some of the factors expected to hamper the growth of the global sterile injectable drugs market over the forecast period. Moreover, the rising demand for injectable drug delivery is driving injectable drugs development and growth of sterile injectable drugs in health management associations.
MARKET SCOPE
The "Stereotactic Breast Biopsy Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of stereotactic breast biopsy market with detailed market segmentation by test, test type and end user. The stereotactic breast biopsy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in stereotactic breast biopsy market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The stereotactic breast biopsy market is segmented on the basis of test, test type and end user. Based on test, the market is segmented . On the basis of test type, the market is categorized as core-needle aspiration and vacuum-assisted core biopsy. On the basis of end user, the market is categorized as hospitals, ambulatory surgical centers and specialty clinics.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the stereotactic breast biopsy market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The stereotactic breast biopsy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting stereotactic breast biopsy market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the stereotactic breast biopsy market in these regions.
Stereotactic Breast Biopsy Market Report Analysis
Stereotactic Breast Biopsy Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX Million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Aurora Imaging Technology Inc
- Devicor Medical Products Inc
- Hologic Inc
- METALTRONICA
- Societa Per Azioni
- Planmed Oy
- Siemens Healthineers
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
By Type
- Biopsy Needles
- Guidance Systems
By Test Type
- Core-needle aspiration
- Vacuum-assisted core biopsy
By End User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
The report covers key developments in the stereotactic breast biopsy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from stereotactic breast biopsy market are anticipated to have lucrative growth opportunities in the future with the rising demand for stereotactic breast biopsy in the global market. Below mentioned is the list of few companies engaged in the stereotactic breast biopsy market.
The report also includes the profiles of key players in stereotactic breast biopsy market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Aurora Imaging Technology, Inc.
- Devicor Medical Products, Inc.
- Hologic, Inc.
- METALTRONICA - Societa' Per Azioni
- Planmed Oy
- Siemens Healthineers
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Stereotactic Breast Biopsy Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ XX Million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2023 - 2031) | XX% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Aurora Imaging Technology, Inc.
2. Devicor Medical Products, Inc.
3. Hologic, Inc.
4. METALTRONICA - Societa' Per Azioni
5. Planmed Oy
6. Siemens Healthineers
1. Aurora Imaging Technology, Inc.
2. Devicor Medical Products, Inc.
3. Hologic, Inc.
4. METALTRONICA - Societa' Per Azioni
5. Planmed Oy
6. Siemens Healthineers
Get Free Sample For